Tikehau Capital, a private equity firm, led a €120m investment in Biobest, a biotechnology company. "The acquisition of Biotrop marks a significant milestone for Biobest, further solidifying our successful M&A strategy alongside our robust organic growth. With the backing of Tikehau Capital's private equity regenerative agriculture strategy, in conjunction with the strategic partnership with AXA and Unilever, Biobest is poised to expedite its expansion efforts, making a substantial contribution to agriculture while fortifying our preeminent position in sustainable crop management," Jean-Marc Vandoorne, Biobest CEO.